Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma

Pathology and Oncology Research

Volumn 13, Issue 4, 2007, Pages 269-275

  Tornóczky, Tamás ^a   Semjén, Dávid ^a   Shimada, Hiroyuki ^b   Ambros, Inge M ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Amplification; Ganglion cell; INPC; LCN; LNN; Maturation; MYCN; Neuroblastoma; Nucleoli; Schwann cell

Indexed keywords

CELL DIFFERENTIATION; CYTOPLASM; GENE AMPLIFICATION; HUMAN; LARGE CELL CARCINOMA; NEUROBLASTOMA; NUCLEOLUS; ONCOGENE C MYB; PHENOTYPE; PROGNOSIS; SHORT SURVEY; TUMOR GROWTH;

EID: 39649091636     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02940304     Document Type: Short Survey

References (14)

1. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B: Terminology and morphologic criteria of neuroblastic tumors. Recommendations by the International Neuroblastoma Pathology Committee. Cancer 86: 349-363, 1999
2. Peuchmaur M, d'Amore ES, Joshi VV, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK. Shimada H: Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98:2274-2281, 2003
3. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP: International Neuroblastoma Pathology Classification (the Shimada System). Cancer 86: 364-372, 1999
4. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK: International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer 92:2451-2461, 2001
5. Shimada H, Chatten J, Newton WA Jr., Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K: Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
6. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
7. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
8. Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H: Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer 92:2699-2708, 2001
9. Tornoczky T, Kalman E, Kajtar P, Nyári T, Pearson A.D.J, Tweddle D, Board J, Shimada H: Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior. Cancer 100:390-397, 2004
10. Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H: Enlarged and prominent nucleoli may be indicative of MYCN amplification. Cancer 103:174-180, 2005
11. Ambros IM, Hata J, Joshi VV, Roald B, Dehner LP, Tüchler H, Pötschger U, Shimada H: Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups. Cancer 94:1574-1583, 2002
12. Boon K, Caron H, Asperen R, Valentijn L, Hermus MC, Sluis P, Roobeek I, Weis I, Voüte PA, Schwab M, Versteeg R: N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 20: 1383-1393, 2001
13. Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW: Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 10:5482-5493, 2004
14. Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG: C-myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66: 673-681, 2006